Latest filing published 13 Jan 2020 for GlaxoSmithKline plc, €14k.
Filing timeline
BuySaleInsider track record
I W Whyte: trading record in brief
All filings by I W Whyte on record concern GlaxoSmithKline plc. In total, 20 filings cover trades dated from 14 July 2016 to 9 January 2020.
Every open-market trade on record is a sale: 1 sale worth €92k. Other entries cover 14 share grants.
Most recently, on 13 January 2020, the filings show a share grant worth €14k in GlaxoSmithKline plc. Between a trade and the moment it shows up on RNS (LSE), the median delay is 1 day. The regulation allows three business days to notify a trade (UK MAR). Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by RNS (LSE) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to I W Whyte
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 663 shares@ £17.90316.0% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20200113110138_14381536_20200331164951975_11111-4
- 682 shares@ £17.2029100.0% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20191011161001_14263725_20200326185154351_23377-2
- 702 shares@ £16.52235.9% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20190712163526_14147423_20200326185124019_23194-2
- 880 shares@ £15.733534.2% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20190412163342_14040049_20200326185043398_13787-1
- 522 shares@ £15.299518.8% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20190115144734_13935414_20200326185116249_17436-1
- 534 shares@ £14.74754.3% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20181017113001_13832379_20200330111442751_12873-1
- 496 shares@ £15.721818.8% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20180713161604_13717916_20200330111420498_14427-1
- 645 shares@ £14.3945.4% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20180413155025_13604520_20200330111353856_14272-1
- 10,984 sharesn/aISIN GB0009252882FCA-NSM:LSE20180222165401_13543105_20200330111412325_5957-2
- 471 shares@ £13.34093.6% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20180115090455_13496097_20200330111417253_16400-1
- 407 shares@ £15.26594.1% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20171013162035_13396747_20200330131537789_9821-1
- 4,360 sharesn/aISIN GB0009252882FCA-NSM:LSE20170810105006_13325816_20200330131543009_6974-1
- 498 shares@ £16.21655.1% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20170714115754_13295823_20200330131517271_10943-1
- 4,690 shares@ £17.0753.7% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20170605172308_13249750_20200330131522014_3718-4
- 1,310 sharesn/aISIN GB0009252882FCA-NSM:LSE20170605172308_13249750_20200330131522014_3718-1
- 587 shares@ £16.42696.7% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20170419163423_13197777_20200330131500011_12349-2
- 7,829 sharesn/aISIN GB0009252882FCA-NSM:LSE20161102164915_013022206_20200330143611976_2193-1
- 371 shares@ £17.03894.1% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20161014171057_013001974_20200330143616319_11065-5
- 2,941 sharesn/aISIN GB0009252882FCA-NSM:LSE20160812160857_012930160_20200330143544421_11077-1
- 344 shares@ £16.58753.8% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20160718170050_012896744_20200330143558405_13592
20 of 20 declarations